Molecular Partners AG

Targeted protein therapeutics beyond antibodies

Molecular Partners is a privately owned biopharmaceutical company, located in Zurich, Switzerland, that is pioneering the development of a novel class of targeted protein therapeutics termed DARPins. DARPins are as target specific and potent as monoclonal antibodies. Yet, being small proteins, they overcome the known limitations of conventional protein-based therapeutic approaches.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

10.06.2025

Molecular Partners vor Massenentlassung (startupticker.ch)

05.11.2024

Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)

31.05.2024

Swiss life science startups headed for San Diego (startupticker.ch)

No Jobs

No videos and documents

>>Venture>>

The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.

Website

CTI Start-up Label

CTI Start-up enables entrepreneurs to realize their innovative idea professionally.

In a process of three phases, over forty experienced coaches guide start-up companies on their way to enter the market successfully and attract financing. At the end of the coaching process, the most promising start-up companies have the opportunity to receive the prestigious CTI Start-up ’Label’. In addition, the companies benefit from the wide CTI Start-up network of industry experts, experienced entrepreneurs, business angels, venture capitalists and has access to foundations such as de Vigier, STI, FIT, Gebert, Rüf, etc.

Until today, CTI Start-up reviewed more than 1 800 projects, and awarded over 200 start-up enterprises with the CTI Start-up Label. Over 85% of these companies are still in business and some have shown remarkable growth, which is a sign that CTI Start-up guides them to sustainable success.

CTI also promotes the culture of entrepreneurship at universities, teaching hospitals, technical institutes as well as universities of applied sciences. CTI Entrepreneurship offers workshops to students on how to bring innovation to the market.

Website

UZH Spin-off

Website

W.A. de Vigier Stiftung

Seit 1987 fördert die W.A. de Vigier Stiftung zukunftweisende Geschäftsideen mit einem Förderpreis von je 5 x CHF 100'000. Nebst diesem Startkapital erhalten die Preisträger auch immaterielle Unterstützung; etwa in Form von wertvollen Kontakten, Medientrainings sowie Präsenz in Presse, TV und Radio. W.A. de Vigier Stiftung versteht ihr Engagement als Beitrag zu einer wettbewerbsstarken und gesunden Schweizer Wirtschaft.

Website

Molecular Partners AG

Targeted protein therapeutics beyond antibodies

Headquarter:
Zürich-Schlieren

Foundation Date:
November 2004

Technology:

  • Biotech

Sectors:

  • Protein drugs